Y-Intercept (HK)
INSM icon

Y-Intercept (HK)’s Insmed INSM Stock Holding History

Y-Intercept (HK)’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$448K Sell
3,926
-97,982
-96% -$11.5M 0.01% 1318
2026
Q2 		$10.9M Buy
+101,908
New +$12.3M 0.22% 77
2025
Q4 		– Sell
-5,884
Closed -$847K – 1756
2025
Q3 		$847K Sell
5,884
-218,418
-97% -$26.8M 0.02% 1054
2025
Q2 		$22.6M Buy
+224,302
New +$17.2M 0.55% 7
2024
Q3 		– Sell
-22,992
Closed -$1.54M – 1544
2024
Q2 		$1.54M Buy
22,992
+15,480
+206% +$600K 0.08% 331
2024
Q1 		$204K Sell
7,512
-17,758
-70% -$497K 0.02% 1148
2023
Q4 		$783K Buy
25,270
+8,987
+55% +$233K 0.07% 414
2023
Q3 		$411K Buy
16,283
+6,589
+68% +$151K 0.04% 639
2023
Q2 		$205K Buy
+9,694
New +$184K 0.02% 933

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Y-Intercept (HK)'s INSM Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Insmed (INSM) stake by 96% in Q3 2026, selling an estimated $11.5M and leaving 3,926 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #1318.

Y-Intercept (HK) first reported a position in INSM in Q2 2023 and has held it in 9 quarters since. The position peaked at $22.6M in Q2 2025. 365 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Y-Intercept (HK) held 3,926 shares of Insmed worth $448K as of Q3 2026.
  • Y-Intercept (HK) sold 97,982 Insmed shares in Q3 2026, an estimated $11.5M.
  • Insmed made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1318 holding.
  • Y-Intercept (HK) first reported a position in Insmed in Q2 2023 and has held it in 9 quarters since.
  • Y-Intercept (HK)'s Insmed position peaked at $22.6M in Q2 2025.
  • 365 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.